Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group).
Journal: World journal of urology
Published: February 05, 2025
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma.
Journal: Current opinion in urology
Published: December 04, 2024
Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance.
Journal: BJUI compass
Published: September 10, 2024
From foes to friends: rethinking the role of lymph nodes in prostate cancer.
Journal: Nature reviews. Urology
Published: June 17, 2024
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.
Journal: Cell communication and signaling : CCS
Published: May 05, 2021
Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population.
Journal: Urologic oncology
Published: February 02, 2020
Nestin+NG2+ Cells Form a Reserve Stem Cell Population in the Mouse Prostate.
Journal: Stem cell reports
Published: March 04, 2019
Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells.
Journal: Nature cell biology
Published: May 22, 2018
Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.
Journal: Nature medicine
Published: June 12, 2017
Last Updated: 09/26/2026